Short Interest in HUTCHMED (China) Limited (NASDAQ:HCM) Declines By 8.1%

HUTCHMED (China) Limited (NASDAQ:HCM) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 467,900 shares, a drop of 8.1% from the November 30th total of 509,300 shares. Based on an average daily volume of 95,100 shares, the days-to-cover ratio is presently 4.9 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered HUTCHMED from a “buy” rating to a “hold” rating in a research note on Monday, November 18th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio purchased a new stake in HUTCHMED during the third quarter valued at about $35,000. Blue Trust Inc. boosted its position in HUTCHMED by 638.2% in the 3rd quarter. Blue Trust Inc. now owns 3,536 shares of the company’s stock valued at $69,000 after buying an additional 3,057 shares during the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in HUTCHMED by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 5,966 shares of the company’s stock worth $117,000 after purchasing an additional 2,321 shares during the last quarter. Rhumbline Advisers increased its stake in shares of HUTCHMED by 8.1% in the second quarter. Rhumbline Advisers now owns 7,553 shares of the company’s stock worth $129,000 after buying an additional 564 shares during the last quarter. Finally, Cubist Systematic Strategies LLC bought a new stake in shares of HUTCHMED in the 2nd quarter worth about $213,000. 8.82% of the stock is currently owned by institutional investors and hedge funds.

HUTCHMED Trading Up 0.3 %

Shares of HCM stock traded up $0.05 during trading hours on Wednesday, reaching $14.41. 39,395 shares of the company’s stock were exchanged, compared to its average volume of 62,801. HUTCHMED has a 1 year low of $11.93 and a 1 year high of $21.92. The company’s 50 day moving average is $16.92 and its two-hundred day moving average is $17.90. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.68 and a current ratio of 2.81.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.